Company Overview of Cardioxyl Pharmaceuticals, Inc.
Cardioxyl Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure; and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded in 2005 and is based in Chapel Hill, North Carolina.
1450 Raleigh Road
Chapel Hill, NC 27517-8833
Founded in 2005
Key Executives for Cardioxyl Pharmaceuticals, Inc.
Cardioxyl Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Spero Therapeutics||United States|
|7 Oaks Pharmaceutical Corp.||United States|
|CreoSalus, Inc.||United States|
|Zurex Pharma, Inc.||United States|
|Akrimax Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Philadelphia, PA | PwCPosted: Mar 19
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Apr 15
- Harrisburg, PA | PwCPosted: Mar 19
- Downers Grove, IL | BelcanPosted: Apr 17
Sponsored Financial Commentaries
To contact Cardioxyl Pharmaceuticals, Inc., please visit www.cardioxyl.com. Company data is provided by Capital IQ. Please use this form to report any data issues.